Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

Beyfortus: A New Respiratory Syncytial Virus (R...

Sanofi’s immunization strategy is taking shape, owing to an authorization that could drive the company and its partner AstraZeneca to the forefront of the respiratory syncytial virus (RSV) treatmen...

Jul 21, 2023

FemTech Market Outlook
Unlocking the Future of Women’s Healthcare Market: The Promise of FemTech

The concept of FemTech has gained immense popularity in recent years. FemTech, an acronym for female technology, refers to the application of technology and innovation to address the health concerns of women and offer solutions that are suited to their particular requirements. It includes a wide range of diagnostic...

Find More
Inflammatory Myositis Treatment Outlook
Analyzing Strategies in Polymyositis and Dermatomyositis Treatment 

Inflammatory myositis refers to a group of disorders affecting the muscles and may be associated with different causes such as infection, drug toxicity, trauma, and autoimmune diseases. The most prominent cause of myositis is an autoimmune disease, typically known as idiopathic inflammatory myopathy (IIM). The indi...

Find More
biomarins-roctavian-first-hemophilia-a-gene-therapy
The Future is Here: BioMarin’s Roctavian First Hemophilia A Gene Therapy Paving the Way for a Cure

Hemophilia A is a rare genetic bleeding disorder that primarily affects males. Hemophilia A is the most common type of hemophilia, accounting for approximately 80% of all cases. It is estimated to occur in about 1 in 5,000 to 10,000 male births. As per the Centers for Disease Control (CDC) (2020), the estimated pre...

Find More

More Views & Analysis

Cloud Computing in Healthcare Industry
Cloud Computing in the Healthcare Industry: Revolutionizing Patient Care

The healthcare industry is witnessing immense growth and transformation owing to the ongoing development and adoption of new and innovative technologies and trends. Electronic Health Records (EHR), telemedicine, telehealth, medical research, and analytics, are some of the key technologies playing a crucial role in ...

Find More

leqembi-for-alzheimers-disease-treatment
Leqembi: A New Hope for Alzheimer’s Disease Patients

Alzheimer’s disease is the most common type of dementia, accounting for more than 60% of all cases, and is characterized by a gradual decline in cognitive and functional abilities. It represents a global health crisis that is increasing with the increasing geriatric population. It represents a global health crisis ...

Find More

liver-cirrhosis-treatment
A Beacon of Hope: A Look at the Latest Advances in Emerging Therapies for Liver Cirrhosis Treatment

Liver cirrhosis is a chronic and progressive condition characterized by the gradual replacement of healthy liver tissue with scar tissue, known as fibrosis. This scarring disrupts the normal structure and function of the liver. It also leads to symptoms such as confusion, ascites, pruritus, weakness, fatigue, and b...

Find More

Nutricosmetics Market Outlook
Evaluating the Evolving Trends in the Nutricosmetics Market: The Intersection of Nutrition and Skincare

The desire for natural beauty that can improve one's health and appearance without having any negative side effects is rising as consumers are becoming more cautious about the food they eat and the products they introduce into their bodies. Nutricosmetics are one such category of product that fit with the modern cu...

Find More

eli-lilly-obesity-treatment-drug-candidates
Eli Lilly’s Obesity Treatment Drug Candidates – A Show for the Competitors

On 26 June 2023, the rush to develop obesity therapies appeared to have raised the bar, as an experimental weight-loss drug from US pharma company Eli Lilly yielded the greatest effects of any treatment observed thus far. The American Diabetes Association’s annual meeting has brought the competitive dynamics of ...

Find More

elevidys-first-gene-therapy-for-dmd-treatment
Sarepta’s ELEVIDYS: First Gene Therapy for Duchenne Muscular Dystrophy (DMD) Treatment

Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease that affects 1 in every 3,500 to 5,000 male neonates worldwide. It is caused by mutations in the gene encoding the protein dystrophin. These genetic changes emerge as developmental delays and, in more severe types of DMD, limb weakness, loss of indep...

Find More

Major Depressive Disorder (MDD), also known as clinical depression, is a severe, debilitating and fr.....

Find More

Digital health technologies can fill the current gaps in oncology care while rebalancing the existin.....

Find More

Multiple myeloma (MM) is a cancer of the blood that begins in the bone marrow. In myeloma, plasma ce.....

Find More

Advances in continuous glucose monitoring (CGM) has led to a paradigm shift in the management of typ.....

Find More

Osteosarcoma is a kind of bone cancer that originates from the cells that form bones. It is often fo.....

Find More

Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by bacteria that have become .....

Find More